Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Glioma. According to GlobalData, Phase I drugs for Glioma have an 81% phase transition success rate (PTSR) ...

This valuable manuscript provides an interesting account documenting the role of resident CD56(br) NK cells in driving interaction with dendritic cells that attract CD8+ T cells to the pancreas cancer ...

EsoGuard uses DNA bisulfite conversion, PCR amplification, and next-generation sequencing to determine the methylation status of 31 sites in the vimentin and cyclin A1 genes, which indicate Barrett's ...

Expression of α-basic-crystallin – Expressed in approximately 50% 33 Increased versus other intrinsic types * BLBC—variously defined (that is not restricted to tumors defined on gene ...